BlackRock Global Sci & Tech Opp Inv B
100 Bellevue Parkway Wilmington, DE 19809
Phone: 800-441-7762
| Category: |
Specialty-Technology |
| Fund Family: |
BlackRock |
| Net Assets: |
8.55M |
| Year-to-Date Return: |
18.33% |
| Yield: |
0.00% |
| Morningstar Rating: |
 |
| Fund Inception Date: |
15-May-00 |
|
Thomas P. Callan
Lead Manager since
15-May-00 |
|
| Callan is a managing director and senior portfolio manager. Before becoming part of BlackRock, Callan had been with the PNC Asset Management Group, which he joined in 1992. He began his career at PNC Bank as a personal trust portfolio manager in 1988 and became a research analyst in 1992. Callan holds the Chartered Financial Analyst designation. |
| Min Initial Investment: |
$1,000 |
| Min Initial Investment, IRA: |
$1,000 |
| Min Initial Investment, AIP: |
$50 |
| Min Subsequent Investment: |
$50 |
| Min Subsequent Investment, IRA: |
$50 |
| Min Subsequent Investment, AIP: |
$50 |
|
|
|
| The investment seeks long-term capital appreciation. The fund normally invests at least 80% of net assets in equity securities issued by science and technology companies in all market capitalization ranges. It invests up to 25% of net assets in stocks of issuers in emerging market countries. The fund invests primarily in equity securities of U.S. and non-U.S. companies in all capitalization ranges. It may invest at least three countries, one of which may be U.S. |
| Last Dividend
|
N/A |
| Last Cap Gain
|
N/A |
| Annual Holdings Turnover
|
92.00% |
| Average for Category:
|
173.43% |
|
| Expense |
BGSBX |
Category
Avg |
| Total Expense Ratio: |
2.50%
|
1.82% |
| Max 12b1 Fee: |
0.75%
|
N/A |
| Max Front End Sales Load: |
0.00%
|
5.16% |
| Max Deferred Sales Load: |
4.50%
|
2.69% |
| 3 Yr Expense Projection*: |
$1,259 |
$758 |
| 5 Yr Expense Projection*: |
$1,774 |
$1,186 |
| 10 Yr Expense Projection*: |
$3,134 |
$2,354 |
|
|
Help
0.09 (1.29%) 
Profile
